Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Sunitinib × Clear all

NCT00451048 2018-09-04

Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Phase 2 Completed

10 enrolled 9 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic